6 studies found for:    "pachyonychia congenita" OR "Keratoderma, Palmoplantar"
Show Display Options
Rank Status Study
1 Completed Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
Condition: Pachyonychia Congenita
Interventions: Drug: TD101;   Drug: Normal saline (placebo)
2 Not yet recruiting Simvastatin Treatment of Pachyonychia Congenita
Condition: Pachyonychia Congenita
Intervention: Drug: Simvastatine
3 Recruiting Topical Sirolimus for Plantar Keratoderma in Adults With Pachyonychia Congenita (PC)
Conditions: Pachyonychia Congenita;   Plantar Keratoderma
Intervention: Drug: Topical Sirolimus
4 Unknown  Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Condition: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A));   Drug: Placebo
5 Completed The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases
Conditions: Basal Cell Carcinoma;   Keratosis Palmaris et Plantaris;   Psoriasis
Intervention:
6 Completed Cytokines in Papillon-Lefèvre Syndrome
Condition: Papillon-Lefevre Disease
Intervention:

Indicates status has not been verified in more than two years